Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADRCs for partial-thickness rotator cuff tears
NCT03752827Active, not recruiting
- Sponsor
- InGeneron
- Start
- May 2019
- Primary completion
- Nov 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous adipose-derived stem/stromal cells in rotator cuff tear (2 arms), sponsored by InGeneron. Primary endpoints: Visual Analog Scale for Pain at 24 weeks and Supraspinatus Strength at 24 weeks. Started May 2019; status: active, not recruiting.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT03752827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752827.